Please login to the form below
CDC
This page shows the latest CDC news and features for those working in and with pharma, biotech and healthcare.
COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
the public and inviting expert groups to participate, including the Israeli Ministry of Health, the University of Bristol in the UK and the CDC. ... However, the controversy around the booster programme may not be over after CDC head, Rochelle Walensky,
Latest news
-
FDA opens door to COVID-19 booster jabs
On reflection, however, the regulators may be out of step with the situation on the ground, as the CDC estimates that more than a million Americans have already had an unauthorised
-
BioNTech to use mRNA technology to develop a ‘highly effective’ malaria vaccine
by the World Health Organization (WHO), which aligns with the African manufacturing strategy launched by the Africa CDC. ... BioNTech will also collaborate with the African Union and the Africa CDC under the partnership for the African Vaccine
-
J&J, distributors reach $26bn settlement to address the opioid crisis in the US
According to the US Centers for Disease Control and Prevention (CDC), overdose deaths involving opioids have increased over six times since 1999.
-
AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues
Data from the US Centers for Disease Control and Prevention (CDC) estimates the rate to be around 0.3 cases per 100, 000 doses of the J&J vaccine.
-
FDA lists rare neurological condition as potential side effect of J&J’s COVID-19 vaccine
According to the US Centers for Disease Control and Prevention (CDC) and FDA, nearly all reports of these events were observed in adult women younger than 50 years old.
FDA opens door to COVID-19 booster jabs
BioNTech to use mRNA technology to develop a ‘highly effective’ malaria vaccine
J&J, distributors reach $26bn settlement to address the opioid crisis in the US
AZ, J&J to research modifications to COVID-19 vaccines over rare blood clot issues
More from news
Approximately 6 fully matching, plus 78 partially matching documents found.
Latest Intelligence
-
Healthcare communications – adapting to ‘the new normal’
WHO and CDC even started to compete with the media as primary sources cited by influencers.
-
The global antibiotic crisis: a 2020 perspective
A report from the CDC says the ‘approaching’ post-antibiotic era is already here. ... According to the 2019 CDC report, over 2.8 million US patients contracted a drug-resistant infection in 2017, and over 35, 000 died as a result.
-
How behavioural design is transforming the role and impact of life sciences in healthcare
II] Up to 40% of annual deaths from each of five leading US causes are preventable, Centers for Disease Control and Prevention (accessed via www.cdc.gov, 26 February 2018).
-
Advancing women in healthcare
Centers for Disease Control and Prevention (CDC) and overseeing a restructuring of the government agency’s multibillion dollar budget and 10, 000 employees.
-
Deal Watch June 2016
US Centers for Disease Control and Prevention (CDC)).
Healthcare communications – adapting to ‘the new normal’
The global antibiotic crisis: a 2020 perspective
How behavioural design is transforming the role and impact of life sciences in healthcare
Advancing women in healthcare
Deal Watch June 2016
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Dr Engelbert Tjeenk Willink joins Allecra Therapeutics
by the US Center for Disease Control (CDC).
Dr Engelbert Tjeenk Willink joins Allecra Therapeutics
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
CDC. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different vaccines/viralvector.html. Published April 13, 2021. Accessed June 10, 2021.
-
5 ways that lockdowns and restrictions could be affecting our allergies
Accessed April 23, 2021. CDC, Published 2021. Resource.
-
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
measles outbreak of 2019 in the US. In 2000, the Centers for Disease Control (CDC) deemed measles eradicated as an endemic disease in the US, but in 2019, an outbreak created
-
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the life sciences
-
Is the world ready for a COVID-19 vaccine?
This isn’t completely new territory; organisations such as the Centers for Disease Control and Prevention (CDC) in the United States, which distributed flu vaccines during the 2009 H1N1 pandemic with
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
5 ways that lockdowns and restrictions could be affecting our allergies
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
- AstraZeneca invests in RNA tech platform
- Market shaping demands behaviour change
- Healthcare Access and Payment Reform in the US
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- David Hunt launches independent agency The Considered
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- WHO to test three more potential COVID-19 treatments
- EU “still interested” in Valneva COVID vaccine despite UK snub
- FDA green lights study of phage-based drug for resistant infections
- First oral antiviral drug for COVID-19 reviewed by Health Canada
PMHub
integrated medhealth communication
imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
